Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Jan 5, 2011


Former National Institutes of Health Director Elias Zerhouni will run global R&D at Sanofi-Aventis, replacing Marc Cluzel, who resigned. Since leaving NIH, Zerhouni has worked as a consultant for Sanofi-Aventis and he has served on the boards at Mayo Clinic and the Lasker Foundation.

Celera has tapped Alfred Merriweather to be senior vice president and CFO. Merriweather previously was executive vice president and CFO at Calypso Medical Technologies, and before that he served as CFO of Monogram Biosciences until it was bought by Laboratory Corporation of America in 2009. Merriweather also has been CFO of Symphonix Devices, Lipomatrix, and Laserscope.

Merriweather replaces Ugo DeBlasi, who left his position with the firm in November.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.